PDX Model Market Worth USD 438.29 Mn. by 2029 Market Analysis, Segment Analysis, Regional Analysis, Growth Opportunities, Challenges, Key Trends and Key Players

November 23 21:37 2022
PDX Model Market Worth USD 438.29 Mn. by 2029 Market Analysis, Segment Analysis, Regional Analysis, Growth Opportunities, Challenges, Key Trends and Key Players
PDX Model Market
PDX Model Market size was valued at USD 155.82 Mn. in 2021 and the total PDX Model revenue is expected to grow at 13.8% from 2022 to 2029, reaching nearly USD 438.29 Mn.

Pune, 23, Nov 2022: Maximize Market research has published a market intelligence and industry analysis report on “PDX Model Market“. The global PDX Model Market was valued at USD 155.82 million in 2021, and is expected to be worth USD 428.29 million by 2029, growing at a CAGR of 13.8% during the forecast period. Maximize Market Research (MMR) encompasses a extensive research methodology for its industry analysis and market intelligence. The PDX Model Market report’s competitive landscape includes details of market key players like company overview and financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, production capacities, company strengths and weaknesses, product launch and application dominance.

Request Sample Copy (To Understand the Complete Structure of this Report [Summary+TOC]) @ https://www.maximizemarketresearch.com/request-sample/162720 

PDX Model Market Scope and Research Methodology

Maximize Market Research’s research proceeds are the result of expert views & analysis,high-quality data, and high-value independent opinions. MMR analyses industry trends and recent developments to identify key growth factors and the forecast of the PDX Model Market. Maximize Market Research’s market intelligence research is designed to deliver a balanced view of the global PDX Model Market and allows stakeholders to make informed decisions to attain their highest growth objectives. MMR’s approach helps build a greater market consensus view for industry trends within each market segment.

Maximize Market Research has analyzed and estimated the PDX Model market using micro and macro factors impacting the market which included primary and secondary research. MMR conducts primary research with industry experts through questionnaires and one-on-one phone interviews. Secondary research includes a synthesis of existing publications across the web to collect significant insights on the current industry situation, technology developments, and other industry-related information. MMR pulls from reliable secondary sources such as white papers and statistics, investor documents, published documents by government organizations and regulatory bodies, company filings, Key Opinion Leaders (KoL) publications, and more.

PDX Model Market Overview

Patient-Derived Xenograft/PDX model development has grown in popularity in recent years, with the idea that such systems will be more relevant than mouse and cell line models, and hence more informative and predictive preclinical treatment models. Recent research has shown that personalised PDX avatars can predict and potentially lead to individualised cancer treatment for individuals. The ability of PDX models to act as real mouse avatars, on the other hand, is predicated on the preservation of each case’s unique molecular features.

PDX Model Market Dynamics

Tumour xenograft and, to a lesser extent, syngeneic models were employed for oncology pharmacology, biomarker, and pharmacokinetics/pharmacodynamics research. The utility of PDX models in routine research operations has grown as the availability and affordability of PDX models given by both academic institutions and contract research enterprises has increased. A brief survey of cancer discovery programmes published in the last three years demonstrates the utilisation of PDX models at various stages of preclinical discovery and translational research.

The practise of developing tailored pharmaceuticals to give customised treatment and care based on personal and genetic differences is known as personalised medicine. These drugs are developed using animal models. In this procedure, immune-deficient animals are transplanted with human tissues, and disease expression is tracked. The model is then subjected to drug/gene therapies in order to find the optimal therapy, which results in suitable or customised pharmaceuticals.

PDX Model Market Regional Insights

The North American market is expected to dominate the patient-derived xenograft/PDX models market, growing at a CAGR of 13.2% during the forecast period. Thanks to the  increase in financing efforts and patient awareness of customised care, North America is expected to witness significant growth, which is followed by Europe. Patient-derived tumour xenografts are widely regarded as important preclinical cancer models.

Large-scale PDX libraries are being produced and utilised for drug development and biomarker screening in Europe and the United States. In 2013, 16 European institutions and governments held “EurOPDX.” So far, over 1500 PDX types, including rare tumours, have been discovered. Furthermore, the Jackson Institute (USA) has begun to make genetic and histological information on over 450 distinct types of PDXs available on their website. Concurrently, the university has begun industrial exploitation of PDXs by commercialising many PDX mouse models.

For Detailed insights on this market, request for methodology here @ https://www.maximizemarketresearch.com/request-sample/162720 

PDX Model Market Segmentation

By Type          

  • Mice Models
  • Rat Models

By Tumor Type         

  • Gastrointestinal Tumor Models
  • Gynecological Tumor Models
  • Respiratory Tumor Models
  • Urological Tumor Models
  • Hematological Tumor Models
  • Other Tumor Models

By Application          

  • Preclinical Drug Development
  • Biomarker Analysis
  • Basic Cancer Research

By End-User   

  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Academic & Research Institutions

PDX Model Market Key Competitors:

  • JSR Corporation
  • WuXi AppTec
  • Champions Oncology, Inc.
  • Charles River Laboratories
  • Oncodesign
  • Envigo
  • Pharmatest Services
  • Hera BioLabs
  • EPO Berlin-Buch GmbH
  • Xentech
  • Urosphere
  • Abnova Corporation
  • Genesis Biotechnology Group
  • Explora BioLabs
  • Biocytogen
  • Living Tumor Laboratory
  • Bioduro
  • Aragen Life Sciences w.e.f,
  • Shanghai Lide Biotech Co., Ltd.
  • Certis Oncology Solutions
  • InnoSer
  • Shanghai ChemPartner Co., Ltd.

Key questions answered in the PDX Model Market are:

  • What is PDX Model?
  • What is the nature of competition in the Motorhome Vehicle industry in developed economies and developing economies?
  • What are the factors affecting growth in the PDX Model Market?
  • What is the growth rate of the PDX Model Market for the next five years?
  • What are the factors for the growth of the Asia-Pacific region in the PDX Model Market?
  • Who are the market leaders in Motorhome Vehicle in Europe?
  • Who are the key players in the PDX Model Market?
  • Who are the market leaders in Motorhome vehicles in India, China, Japan, and South Korea?
  • Who are the market leaders in Motorhome Vehicle in USA and Canada?
  • Who held the largest market share in PDX Model Market?

Key Offerings:

  • Market Share, Size & Forecast by Revenue | 2022−2029
  • Market Dynamics – Growth Drivers, Restraints, Investment Opportunities, and Key Trends
  • Market Segmentation – A detailed analysis by Segment and Region
  • Competitive Landscape – Top Key Vendors and Other Prominent Vendors

Maximize Market Research is leading healthcare research firm, has also published the following reports:

Sarcoma Drugs MarketThe Sarcoma Drugs Market is expected to reach USD 1405.3 million by 2029 at a CAGR of 23 percent during the forecast period. Growing use of immunotherapy for the treatment of sarcoma and increasing cancer prevalence to support sarcoma drugs is expected to drive the Sarcoma Drugs Market.

Alzheimer’s Therapeutics Market: The Alzheimer’s Therapeutics Market is expected to reach USD 18.46 billion by 2029 at a CAGR of 19.3 percent during the forecast period. High adoption of biomarkers in diagnosis and drug development is expected to drive Alzheimer’s Therapeutics Market.

Microfluidics Market: The Microfluidics Market is expected to reach USD 74.68 billion by 2029 at a CAGR of 17.2 percent during the forecast period. Technologically advanced systems such as implantable drug delivery systems can provide significant market growth, further driving the growth of Microfluidics Market.

About Maximize Market Research:

Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.

Contact Maximize Market Research:

3rd Floor, Navale IT Park, Phase 2

Pune Banglore Highway, Narhe,

Pune, Maharashtra 411041, India

[email protected]

+91 96071 95908, +91 9607365656

Media Contact
Contact Person: Geeta Yevle
Email: Send Email
Address:3rd Floor, Navale IT Park, Phase 2, Pune Banglore Highway, Narhe,
City: Pune
State: Maharashtra
Country: India
Website: https://www.maximizemarketresearch.com/market-report/pdx-model-market/162720/